Science Explorer Back to mapMap

Most cited papers from Gulf Medical University

What are the most cited papers from Gulf Medical University?

The most cited paper from Gulf Medical University is "A simple practice guide for dose conversion between animals and human" (Anroop Balachandran Nair, Shery Jacob, 2016), with 6,160 citations. Next come "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1" (2,743) and "Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023" (762).

Showing 50 of 60 papers. Every paper with more than 114 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A simple practice guide for dose conversion between animals and human Anroop Balachandran Nair, Shery Jacob · Journal of Basic and Clinical Pharmacy Open access 2016 6,160
2 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
3 Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Simon I Hay et al. · The Lancet Open access2,780 authors Oct 2025 762
4 Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors Oct 2025 500
5 Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management Shery Jacob, Anroop Balachandran Nair, Jigar Shah et al. · Pharmaceutics Open access 8 Mar 2021 480
6 Dose translation between laboratory animals and human in preclinical and clinical phases of drug development Anroop Balachandran Nair, Mohamed Aly Morsy, Shery Jacob · Drug Development Research 21 Oct 2018 476
7 Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives Hossam S. El‐Sawy, Ahmed Mohamed Al-Abd, Tarek A. Ahmed et al. · ACS Nano 17 Oct 2018 435
8 Emerging role of nanosuspensions in drug delivery systems Shery Jacob, Anroop Balachandran Nair, Jigar Shah · Biomaterials Research Open access 15 Jan 2020 415
9 Testosterone and Metabolic Syndrome: A Meta-Analysis Study Giovanni Corona, Matteo Monami, Giulia Rastrelli et al. · The Journal of Sexual Medicine Review 31 Aug 2010 402
10 Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 Patrick B Mark et al. · The Lancet Open access597 authors Nov 2025 366
11 Fifty‐ two—Week Treatment With Diet and Exercise Plus Transdermal Testosterone Reverses the Metabolic Syndrome and Improves Glycemic Control in Men With Newly Diagnosed Type 2 Diabetes and Subnormal Plasma Testosterone Armin E. Heufelder, Farid Saad, Mathijs C. M. Bunck et al. · Journal of Andrology 21 Oct 2009 348
12 Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study Svetlana Y. Kalinchenko, Yuliya A. Tishova, George J. Mskhalaya et al. · Clinical Endocrinology 13 Aug 2010 338
13 The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 Lisa M Force et al. · The Lancet Open access1,377 authors 25 Sep 2025 330
14 Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics Ramalingam Peraman, Kalva Bhadraya, Y. Padmanabha Reddy · International Journal of Analytical Chemistry Open access 2015 292
15 The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction Abdulmaged M. Traish, André T. Guay, Robert J. Feeley et al. · Journal of Andrology Open access 3 Dec 2008 286
16 The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance Abdulamaged M. Traish, Farid Saad, André T. Guay · Journal of Andrology 3 Dec 2008 266
17 A multinational study on the factors influencing university students’ attitudes and usage of ChatGPT Maram Abdaljaleel et al. · Scientific Reports Open access 23 Jan 2024 262
18 COVID-19 and metabolic disease: mechanisms and clinical management Charlotte Steenblock et al. · The Lancet Diabetes & Endocrinology Open access 5 Oct 2021 255
19 Cyclodextrin complexes: Perspective from drug delivery and formulation Shery Jacob, Anroop Balachandran Nair · Drug Development Research Aug 2018 254
20 The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease Abdulmaged M. Traish, Farid Saad, Robert J. Feeley et al. · Journal of Andrology 26 Aug 2009 239
21 Dehydroepiandrosterone (DHEA)—A Precursor Steroid or an Active Hormone in Human Physiology (CME) Abdulmaged M. Traish, H. Paco Kang, Farid Saad et al. · The Journal of Sexual Medicine 27 Oct 2011 239
22 Onset of effects of testosterone treatment and time span until maximum effects are achieved Farid Saad, Antônio Aversa, Andrea Maria Isidori et al. · European Journal of Endocrinology Open access 13 Jul 2011 231
23 Assessing Health Students' Attitudes and Usage of ChatGPT in Jordan: Validation Study Malik Sallam, Nesreen A. Salim, Muna M. Barakat et al. · JMIR Medical Education Open access 14 Aug 2023 226
24 Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges Muhammad Zaeem Noman, Meriem Hasmim, Audrey Lequeux et al. · Cells Open access 14 Sep 2019 214
25 THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study Giovanni Corona, Vito Angelo Giagulli, Elisa Maseroli et al. · European Journal of Endocrinology Review 4 Nov 2015 214
26 Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies Raefa Abou Khouzam, Klaudia K. Brodaczewska, Aleksandra Filipiak-Duliban et al. · Frontiers in Immunology Open access 20 Jan 2021 205
27 Herbal Medicines Use During Pregnancy: A Review from the Middle East Lisha Jenny John, Nisha Shantakumari · Oman Medical Journal Open access 15 Jul 2015 198
28 Global, regional, and national sepsis incidence and mortality, 1990–2021: a systematic analysis Authia P Gray et al. · The Lancet Global Health Open access472 authors 22 Oct 2025 194
29 A Systematic Review of Self-Medication Practices Among Adolescents Syed Ilyas Shehnaz, Anoop Kumar Agarwal, Nelofer Khan · Journal of Adolescent Health ReviewOpen access 19 Sep 2014 194
30 Testosterone supplementation and body composition: results from a meta-analysis of observational studies Giovanni Corona, Vito Angelo Giagulli, Elisa Maseroli et al. · Journal of Endocrinological Investigation Review 30 May 2016 186
31 Long‐term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long‐term registry study Abdulmaged M. Traish, Ahmad M. Haider, Gheorghe D. Doros et al. · International Journal of Clinical Practice Open access 15 Oct 2013 185
32 Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit Linda Vignozzi, Annamaria Morelli, Erica Sarchielli et al. · Journal of Endocrinology Open access 18 Oct 2011 185
33 Computer use and vision-related problems among university students in Ajman, United Arab Emirate Nisha Shantakumari, Rasha Ali Eldeeb, Jayadevan Sreedharan et al. · Annals of Medical and Health Sciences Research Open access 2014 185
34 An Updated Overview of the Emerging Role of Patch and Film-Based Buccal Delivery Systems Shery Jacob, Anroop Balachandran Nair, Sai H. S. Boddu et al. · Pharmaceutics Open access 5 Aug 2021 175
35 An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs Shery Jacob, Anroop Balachandran Nair · Drugs in R&D Open access 20 Oct 2016 173
36 Curcuma zedoaria Rosc. (white turmeric): a review of its chemical, pharmacological and ethnomedicinal properties Richard Lobo, Kirti S. Prabhu, Annie Shirwaikar et al. · Journal of Pharmacy and Pharmacology 27 Dec 2008 169
37 Adapting to the impact of COVID-19: Sharing stories, sharing practice Jennifer Cleland, Judy McKimm, Richard Fuller et al. · Medical Teacher 13 May 2020 168
38 Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study Aksam A Yassin, Ahmad M. Haider, Karim Sultan Haider et al. · Diabetes Care 12 Mar 2019 165
39 Ocimum gratissimum: A Review of its Chemical, Pharmacological and Ethnomedicinal Properties Kirti S. Prabhu, Richard Lobo, Arun Shirwaikar et al. · The Open Complementary Medicine Journal Open access 20 Feb 2009 164
40 Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities Hanan A. Bashmail, Aliaa A. Alamoudi, Abdulwahab A. Noorwali et al. · Scientific Reports Open access 30 Jul 2018 163
41 Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy—An Overview on Recent Advances Shery Jacob, Anroop Balachandran Nair, Jigar Shah et al. · Pharmaceutics Open access 27 Feb 2022 159
42 Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence Abdulmaged M. Traish, José Bolaños, Sunil Sukumaran Nair et al. · Journal of Clinical Medicine Open access 14 Dec 2018 153
43 The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process Thomas Hugh Jones, Farid Saad · Atherosclerosis 25 Apr 2009 151
44 Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment Etienne D. Foucher, Clément Ghigo, Salem Chouaı̈b et al. · Frontiers in Immunology Open access 14 May 2018 150
45 Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways Hany H. Arab, Muhammad Y. Al‐Shorbagy, Muhammed A. Saad · Chemico-Biological Interactions 4 Jan 2021 149
46 The Digital Health Competencies in Medical Education Framework Josip Car et al. · JAMA Network Open Open access 31 Jan 2025 148
47 Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Dana Bryazka et al. · The Lancet Public Health Open access1,009 authors Oct 2024 148
48 Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport Shivani J. Gandhi, Divyesh Harshadkumar Shastri, Jigar Shah et al. · Pharmaceutics Open access Apr 2024 144
49 Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer–Mediated Cytotoxicity Antoun Al Absi, Hannah Wurzer, Coralie L. Guérin et al. · Cancer Research Open access 13 Aug 2018 142
50 Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome Erik J. Giltay, Yuliya A. Tishova, George J. Mskhalaya et al. · The Journal of Sexual Medicine 27 May 2010 140

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.